Goldman Sachs
HCAR

Goldman Sachs’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Goldman Sachs’s Portfolio HCAR Stock Details HCAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-894,449
Closed -$8.88M – 6460
2022
Q3 		$8.88M Buy
894,449
+20,082
+2% +$199K ﹤0.01% 2622
2022
Q2 		$8.6M Buy
874,367
+268,581
+44% +$2.64M ﹤0.01% 2657
2022
Q1 		$5.94M Buy
605,786
+63,100
+12% +$616K ﹤0.01% 3196
2021
Q4 		$5.3M Sell
542,686
-61,700
-10% -$603K ﹤0.01% 3352
2021
Q3 		$5.89M Sell
604,386
-62,467
-9% -$605K ﹤0.01% 3216
2021
Q2 		$6.46M Buy
666,853
+216,404
+48% +$2.1M ﹤0.01% 3113
2021
Q1 		$4.36M Buy
+450,449
New +$4.51M ﹤0.01% 3253

Goldman Sachs's HCAR Position: Q4 2022 in Review

Goldman Sachs sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 894,449 shares — an estimated $8.88M sold.

Goldman Sachs first reported a position in HCAR in Q1 2021 and held it in 7 quarters. The position peaked at $8.88M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Goldman Sachs reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 894,449 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $8.88M.
  • Goldman Sachs first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Goldman Sachs's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $8.88M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.